Binder Information
Binder General Information | Top | |||
---|---|---|---|---|
Binder ID |
B5FX1D
|
|||
Binder Name |
4-[3-(4-Methoxyphenyl)-5-phenyl-3,4-dihydropyrazol-2-yl]benzenesulfonamide
|
|||
Synonyms |
ML141; ML 141; ML-141; CID-2950007; MLS000693334; MLS002699035; KUC103352N-2; SMR000299863; 4-[5-(4-methoxyphenyl)-3-phenyl-4,5-dihydro-1H-pyrazol-1-yl]benzenesulfonamide; 4-[4,5-dihydro-5-(4-methoxyphenyl)-3-phenyl-1H-pyrazol-1-yl]-benzenesulfonamide; 4-(5-(4-Methoxyphenyl)-3-phenyl-4,5-dihydro-1H-pyrazol-1-yl)benzenesulfonamide; MLS006011906; CHEMBL1370630; SCHEMBL12494043; BDBM43220; cid_2950007; AOB1515; HMS2688G07; KUC103352N; BCP13193; EX-A1165; 2551AH; KSC-6-125; MFCD05987165; s7686; SBB085162; STL259581; AKOS000296683; AKOS022118974; KUC103352N-03; CCG-268734; CS-3940; KSC-23-233; MCULE-5226073572; CID 2950007; NCGC00263209-01; NCGC00263209-02; NCGC00263209-09; AC-33173; AK205799; AS-16658; HY-12755; ML 141, >=98% (HPLC); UNM-0000305822; UNM-0000305868; UNM-0000306066; US9388139, 11; SR-01000271680; SR-01000271680-1; Q27163444; 4-[5-(4-methoxyphenyl)-3-phenyl-2-pyrazolinyl]benzenesulfonamide; 4-[5-(4-methoxyphenyl)-3-phenyl-2-pyrazolin-1-yl]benzenesulfonamide; 4-(5-(4-methoxyphenyl)-3-phenyl-4,5-dihydro-1Hpyrazol-1-yl)benzenesulfonamide; 4-[4,5-Dihydro-5-(4-methoxyphenyl)-3-phenyl-1H-pyrazol-1-yl]benzenesulfonamide; 4-[5-(4-METHOXYPHENYL)-3-PHENYL-4,5-DIHYDROPYRAZOL-1-YL]BENZENESULFONAMIDE
Click to Show/Hide
|
|||
Binder Type |
Small molecular drug
|
|||
Structure |
![]() |
Download2D MOL |
||
Formula |
C22H21N3O3S
|
|||
Canonical SMILES |
COC1=CC=C(C=C1)C2CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C4=CC=CC=C4
|
|||
InChI |
1S/C22H21N3O3S/c1-28-19-11-7-17(8-12-19)22-15-21(16-5-3-2-4-6-16)24-25(22)18-9-13-20(14-10-18)29(23,26)27/h2-14,22H,15H2,1H3,(H2,23,26,27)
|
|||
InChIKey |
QBNZBMVRFYREHK-UHFFFAOYSA-N
|
|||
PubChem Compound ID | ||||
ChEBI ID |
CHEBI:91613
|
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.